TRASTUZUMAB DERUXTECAN
Clinical trials for TRASTUZUMAB DERUXTECAN explained in plain language.
Never miss a new study
Get alerted when new TRASTUZUMAB DERUXTECAN trials appear
Sign up with your email to follow new studies for TRASTUZUMAB DERUXTECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Real-world data on targeted drug for advanced breast cancer in russia
Disease control Recruiting nowThis study is looking at how well the drug trastuzumab deruxtecan works in Russian patients with advanced HER2-positive breast cancer that cannot be removed by surgery or has spread. Researchers will review medical records from 60 patients who have already received the drug to se…
Matched conditions: TRASTUZUMAB DERUXTECAN
Phase: NA • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Can switching breast cancer drugs buy more time? new study aims to find out.
Knowledge-focused Recruiting nowThis study is for people with advanced HER2-positive breast cancer whose current treatment (trastuzumab deruxtecan) has stopped working. Researchers want to see if switching immediately to another targeted drug (trastuzumab emtansine) can help control the cancer longer. About 100…
Matched conditions: TRASTUZUMAB DERUXTECAN
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:00 UTC